| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Revenues: | ||||||||
Gross written premiums | ||||||||
269,424 | 251,961 | 222,141 | 195,893 | 174,889 | 154,891 | 0 | 0 | 0 |
Ceded written premiums | ||||||||
111,721 | 108,332 | 100,547 | 93,251 | 95,293 | 82,949 | 0 | 0 | 0 |
Net written premiums | ||||||||
157,703 | 143,629 | 121,594 | 102,642 | 79,596 | 71,942 | 0 | 0 | 0 |
Change in unearned premiums | ||||||||
-41,040 | -43,422 | -34,779 | -27,453 | -9,336 | -2,045 | 0 | 0 | 0 |
Net earned premiums | ||||||||
116,663 | 100,207 | 86,815 | 75,189 | 70,260 | 69,897 | 0 | 0 | 0 |
Net investment income | ||||||||
7,050 | 5,975 | 5,199 | 4,335 | 3,581 | 3,238 | 0 | 0 | 0 |
Net realized and unrealized gains on investments | ||||||||
2,472 | 4,443 | -274 | 701 | 463 | -2,569 | 0 | 0 | 0 |
Commission and other income | ||||||||
2,823 | 2,671 | 2,573 | 2,543 | 2,451 | 2,405 | 0 | 0 | 0 |
Total revenues | ||||||||
129,008 | 113,296 | 94,313 | 82,768 | 76,755 | 72,971 | 0 | 0 | 0 |
Expenses: | ||||||||
Losses and loss adjustment expenses | ||||||||
7,140 | 5,593 | 2,628 | 5,563 | 5,652 | 6,274 | 0 | 0 | 0 |
Acquisition expenses | ||||||||
43,330 | 37,259 | 32,781 | 28,930 | 27,409 | 28,224 | 0 | 0 | 0 |
Other underwriting expenses (includes stock-based compensation of $442 and $22,961 for the three months ended March 31, 2020 and 2019, respectively) | ||||||||
30,397 | 51,299 | 49,185 | 45,831 | 43,005 | 17,957 | 0 | 0 | 0 |
Interest expense | ||||||||
- | 1,068 | 1,928 | 2,533 | 2,328 | 2,303 | 0 | 0 | 0 |
Total expenses | ||||||||
81,506 | 95,219 | 86,522 | 82,857 | 78,394 | 54,758 | 0 | 0 | 0 |
Income (loss) before income taxes | ||||||||
47,502 | 18,077 | 7,791 | -89 | -1,639 | 18,213 | 0 | 0 | 0 |
Income tax expense | ||||||||
10,695 | 7,456 | 3,923 | 1,931 | 145 | -6 | 0 | 0 | 0 |
Net income | ||||||||
36,807 | 10,621 | 3,868 | -2,020 | -1,784 | 18,219 | 0 | 0 | 0 |
Other comprehensive income, net: | ||||||||
Net unrealized gains (losses) on securities available for sale for the three months ended March 31, 2020 and 2019, respectively | ||||||||
-2,771 | 5,249 | 7,417 | 6,134 | 2,745 | -341 | 0 | 0 | 0 |
Net comprehensive income (loss) | ||||||||
34,036 | 15,870 | 11,285 | 4,114 | 961 | 17,878 | 0 | 0 | 0 |
Per Share Data: | ||||||||
Basic earnings per share | ||||||||
0.49 | 0.72 | 0.32 | 0.30 | -0.85 | - | 0.09 | 0.41 | - |
Diluted earnings per share | ||||||||
0.48 | 0.73 | 0.31 | 0.30 | -0.85 | - | 0.09 | 0.41 | - |
Weighted-average common shares outstanding: | ||||||||
Earnings per share, basic and diluted | ||||||||
- | - | - | - | - | - | - | - | 0.33 |
Weighted-average common shares outstanding: | ||||||||
- | - | - | - | - | - | - | - | 17,000 |
Weighted-average common shares outstanding, basic | ||||||||
24,119 | 23,561 | 23,468 | 21,975 | 17,000 | - | 17,000 | 17,000 | - |
Weighted-average common shares outstanding, diluted | ||||||||
24,778 | 24,349 | 23,885 | 22,105 | 17,000 | - | 17,000 | 17,000 | - |